Home › Funds › EARNEST PARTNERS LLC › QGEN

EARNEST PARTNERS LLC position in QGEN

QIAGEN NV · Health Care

EARNEST PARTNERS LLC reported holding 4,652,297 shares of QGEN (QIAGEN NV) in its Q3 2026 13F filing — a position valued at US$203.6M, representing 0.80% of its reported portfolio and ranking #36 among its reported holdings. EARNEST PARTNERS LLC has disclosed QGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.65M sh
Reported value held$203.58M
Portfolio Weight0.80%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EARNEST PARTNERS LLC's QGEN position evolved

EARNEST PARTNERS LLC first disclosed a stake in QGEN in Q3 2023 at 1,511,503 shares (US$61.2M). The position peaked in Q3 2026 at 4,652,297 shares, worth US$203.6M. Across 13 filings, EARNEST PARTNERS LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 4,652,297 shares valued at US$203.6M — an increase of 78,842 shares quarter over quarter.. Notable position changes include a 85% increase in Q1 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.51M $61.22M New
Q4 2023 1.85M $82.89M Add
Q1 2024 3.43M $147.35M Add
Q2 2024 3.81M $156.44M Add
Q3 2024 3.94M $179.45M Add
Q4 2024 4.00M $178.23M Add
Q1 2025 3.81M $152.84M Reduce
Q2 2025 4.20M $201.96M Add
Q3 2025 4.21M $188.03M Hold
Q4 2025 4.19M $188.33M Hold
Q1 2026 3.87M $154.89M Reduce
Q2 2026 4.57M $178.82M Add
Q3 2026 4.65M $203.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QGEN and 13F data

QGEN (QIAGEN NV) is a Health Care company. 27 other funds we track also report a position in QGEN — the largest reported positions include Fivespan Partners, LP (US$237.6M), Helikon Investments Ltd (US$100.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QGEN

All QGEN fund holders →

FAQ

How long has EARNEST PARTNERS LLC held QGEN?

EARNEST PARTNERS LLC has disclosed QGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EARNEST PARTNERS LLC's current position in QGEN?

As of Q3 2026, EARNEST PARTNERS LLC holds 4.65M shares of QGEN (QIAGEN NV), valued at $203.58M, representing 0.80% of its reported portfolio and ranking #36.

Has EARNEST PARTNERS LLC been buying or selling QGEN?

In the latest 13F filing (Q3 2026), EARNEST PARTNERS LLC increased its position in QGEN. The position peaked in Q3 2026 at 4.65M shares.

Which other funds hold QGEN?

Other major institutional holders of QGEN include Fivespan Partners, LP, Helikon Investments Ltd, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.